We are pleased to announce the addition of bezafibrate to the Primary Biliary Cholangitis (PBC) indication of the Hepatology Drug Interaction checker. Bezafibrate can be used off-label for PBC in patients who do not respond to ursodeoxycholic acid.
All our Interaction Summary Tables have been updated to include bezafibrate, and a downloadable update is available for our mobile apps.
Find the PK Factsheet for bezafibrate here.
One comedication was added to the interaction checker this month: Pancreatic enzymes (pancrelipase, pancreatin) to the class Other.
